Trial intelligence / Profile preview

Domestic-setting efficacy and safety of Lybrido and Lybridos in women with female sexual dysfunction on SSRIs

2008-002735-32Phase 2Terminated

Sponsor
Emotional Brain
Start
May 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of sildenafil + testosterone and Lybridos in hypoactive sexual desire disorder (HSDD) and Sexual Arousal Disorder (3 arms), sponsored by Emotional Brain. Primary endpoint: Subjective sexual functioning. Started May 2008; status: terminated.

02

Drugs

sildenafil + testosteroneLybridos
03

Conditions

hypoactive sexual desire disorder (HSDD)Sexual Arousal Disorder

Beyond the preview

Go deeper on 2008-002735-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-002735-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call